Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study.

Antioxidants (Basel) · 2022 · PMC8772895 · PMID 35052620

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Overall changes in NPDR stages (improvement, no change, worsening) were statistically significant in the placebo group at 6 months ( p = 0.045) compared with the DHA group, but between-group differences at 12 months ( p = 0.825), 18 months ( p = 0.931), and 24 months ( p = 0.526) did not reach statistical significance. 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.